Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

420
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
420
Renal Corpuscle01:20

Renal Corpuscle

1.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.8K
Glaucoma: Overview01:25

Glaucoma: Overview

532
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
532

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026
Same author

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop.

Kidney international reports·2026
Same author

Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis.

Clinical kidney journal·2025
Same author

ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.

Med (New York, N.Y.)·2025
Same author

A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING).

BMC nephrology·2024
Same author

Prospective study of the effect of rituximab on kidney function in membranous nephropathy.

Clinical kidney journal·2024
Same journal

Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Prolonged Undiagnosed Prodromal Symptoms.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Human Factors and Deterioration: What Success Factors Facilitate Escalation of Care and How Can These Be Applied More Reliably?

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Comparative Evaluation of Functional Outcomes and Postoperative Complications After Minimally Invasive Fixation for Acromioclavicular Joint Injuries.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

A Systematic Review of Functional MRI Studies on Seasonal Modulation of Brain Functional Connectivity.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

More Than Myocarditis? Cardiac Involvement in Phaeochromocytoma-A Case Report.

British journal of hospital medicine (London, England : 2005)·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2025

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

9.1K

Advances in primary glomerulonephritis.

Betsy Ellison1, Ruzaika Cader1, Lisa Willcocks1

  • 1Department of Nephrology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

British Journal of Hospital Medicine (London, England : 2005)
|July 30, 2024
PubMed
Summary
This summary is machine-generated.

Primary glomerulonephritis, including IgA nephropathy (IgAN) and FSGS, causes kidney disease. New treatments and KDIGO guidelines offer hope for reducing progression to end-stage kidney disease.

Keywords:
Focal segmental glomerulosclerosisIgA nephropathyMembranous glomerulonephritisMinimal change disease

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K
An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney
10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

13.6K

Related Experiment Videos

Last Updated: Jun 18, 2025

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

9.1K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K
An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney
10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

13.6K

Area of Science:

  • Nephrology
  • Immunology

Background:

  • Primary glomerulonephritis encompasses IgA nephropathy (IgAN), primary membranous nephropathy (PMN), Focal Segmental Glomerulosclerosis (FSGS), and Minimal Change Disease (MCD).
  • These rare renal diseases lead to significant healthcare costs due to end-stage kidney disease (ESKD) requiring dialysis or transplantation.
  • The pathogenesis of primary glomerulonephritis was historically unclear, impacting treatment strategies.

Purpose of the Study:

  • To review current Kidney Disease Improving Global Outcomes (KDIGO) guidelines for treating IgAN, PMN, FSGS, and MCD.
  • To discuss recent advancements in understanding the pathogenesis of these glomerulonephritides.
  • To highlight novel therapeutic agents and ongoing clinical trials impacting patient care.

Main Methods:

  • Literature review of international KDIGO guidelines.
  • Synthesis of recent research on the pathogenesis of primary glomerulonephritis.
  • Analysis of data from completed and ongoing clinical trials for novel treatments.

Main Results:

  • Recent advances in understanding disease evolution have led to new therapeutic agents.
  • Clinical trials show significant potential to alter the standard of care for primary glomerulonephritides.
  • These developments are expected to reduce the number of patients progressing to ESKD.

Conclusions:

  • Novel therapeutic strategies and updated KDIGO guidelines are transforming the management of primary glomerulonephritis.
  • Improved understanding of pathogenesis is driving the development of more effective treatments.
  • The outlook for patients with IgAN, PMN, FSGS, and MCD is improving, with a potential decrease in ESKD incidence.